Patients Choose Unproven Peptides Over Proven Heart Drugs, Doctor Says
Patients are refusing statins, heart drugs backed by studies of 170,000 people, but want peptide treatments with little research behind them. Doctor Vikas Patel says this shows people trust medicine less when there's more evidence for it.
Patients are turning away from some of the most studied drugs in medicine while seeking out treatments with almost no research backing them up.
Doctor Vikas Patel wrote that patients in his practice refuse statins weekly. These heart drugs have been tested in studies with over 170,000 people and reduce major heart problems by 25 percent.
At the same time, patients ask for peptides like BPC-157. These treatments have little scientific evidence but are popular online and in wellness circles.
Patel says this creates an uncomfortable truth: the more evidence behind a treatment, the less people seem to trust it. Meanwhile, peptides get attention despite having undocumented risks.
The problem isn't just about safety data. Companies don't study many peptides because it's too expensive and they can't patent natural compounds. This leaves doctors unable to recommend treatments that might help because there's no formal research.
Patients can take medications with known side effects that were discovered after approval. But they can't access peptides with unknown risks, not because they're proven harmful, but because studying them isn't profitable.
This trend could put your health at risk if you skip proven treatments for trendy alternatives. It also shows how people are losing trust in traditional medicine, even when the science is solid.
Watch for more FDA regulations on peptide therapy and whether trust in traditional medicine continues declining.
Was this article helpful?
0 people found this helpful